Abstract: A stream condense unit coupled to a streaming server and a client player is provided. The stream condense unit includes a streaming data input unit, a stream content analysis unit, a frame timestamp adjust unit, and a streaming data output unit. The streaming data input unit is configured to receive a plurality of streaming content groups sent by the streaming server. The stream content analysis unit is configured to receive the plurality of streaming content groups, execute a content analysis to get importance scores of the source streaming contents. The frame timestamp adjust unit is configured to receive the condensed stream and adjust a timestamp of each frame in the condensed stream. The streaming data output unit is configured to receive the condensed stream and attach content identifying labels and tables to the condensed stream, and send the condensed stream to the client player to display.

Abstract: A stream condense unit coupled to a streaming server and a client player is provided. The stream condense unit includes a streaming data input unit, a stream content analysis unit, a frame timestamp adjust unit, and a streaming data output unit. The streaming data input unit is configured to receive a plurality of streaming content groups sent by the streaming server. The stream content analysis unit is configured to receive the plurality of streaming content groups, execute a content analysis to get importance scores of the source streaming contents. The frame timestamp adjust unit is configured to receive the condensed stream and adjust a timestamp of each frame in the condensed stream. The streaming data output unit is configured to receive the condensed stream and attach content identifying labels and tables to the condensed stream, and send the condensed stream to the client player to display.

Abstract: The present invention provides a DNA vaccine, which comprises a DNA construct comprising an expression vector which is expressible in a eukaryotic cell, and a nucleotide fragment which comprises an IL-6-encoding sequence and an HPV E7-encoding sequence. In addition, the present invention also provides a pharmaceutical composition and a method of generating said DNA vaccine.

Abstract: The present invention provides a DNA vaccine, which comprises a DNA construct comprising an expression vector which is expressible in a eukaryotic cell, and a nucleotide fragment which comprises a CTGF-encoding sequence and a HPV sequence selected from an E6-encoding sequence, an E7-encoding sequence, or a combination thereof. In addition, the present invention also provides a pharmaceutical composition and a method of generating said DNA vaccine.

Abstract: The present invention relates to a super-antigen fusion protein, comprising: a peptide fragment whose sequence corresponds to a partial SARS E2 spike protein; and a translocating peptide fragment for transporting a protein into a cell and translocating the protein in cytosol; wherein, the amino acid sequence of the peptide fragment corresponding to the partial SARS E2 spike protein includes SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3 or SEQ ID NO. 4. The present invention further relates to DNA sequences corresponding to the partial SARS E2 spike protein includes SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, or SEQ ID NO. 8; wherein the DNA sequences are able to express specific proteins in an E. Coli expression system.

Abstract: The present invention provides a DNA vaccine, which comprises a DNA construct comprising an expression vector which is expressible in a eukaryotic cell, and a nucleotide fragment which comprises an IL-6-encoding sequence and an HPV E7-encoding sequence. In addition, the present invention also provides a pharmaceutical composition and a method of generating said DNA vaccine.

Abstract: A system for real-time media communication comprises a first server unit configured to interface between at least one user and a blog and a second server unit configured to process the real-time media content in a streaming mode. The first server unit comprises a publishing control module configured to identify an identity of a publisher of the at least one user, allow the publisher to transmit real-time media content if the identity of the publisher is authentic and receive a description of the real-time media content from the publisher, and a link module configured to obtain a location of the real-time media content so that the location of the real-time media content is accessible to the at least one user. The second server unit comprises a receiving module configured to receive the real-time media content, a recording module configured to record the real-time media content, and a dispatching module configured to provide the location of the real-time media content to the publishing module.

Abstract: A fusion protein for inhibiting cervical cancer is disclosed, which comprises a peptide sequence of human papillomavirus type 16, a peptide translocating peptide for translocation, and a peptide within a carboxyl terminal fragment. The present invention further comprising a composition of antibody, which conjugates to E7 peptide, wherein the nucleotide sequence corresponding to the amino acid sequence of the E7 peptide is shown as SEQ. ID. NO.1.

Abstract: The present invention relates to a super-antigen fusion protein, comprising: a peptide fragment encoding a partial SARS E2 spike protein; and a translocating peptide fragment for transporting a protein into a cell and translocating the protein in cytosol; wherein, the amino acid of the peptide fragment encoding the partial SARS E2 spike protein includes SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or SEQ ID NO.4. The present invention further relates to DNA sequences encoding the partial SARS E2 spike protein includes SEQ ID NO.5, SEQ ID NO.6, SEQ ID NO.7, or SEQ ID NO.8; wherein the DNA sequences are able to express specific proteins in an E. Coli expression system.

Abstract: A fusion protein for inhibiting cervical cancer is disclosed, which comprises a peptide sequence of human papillomavirus type 16, a peptide translocating peptide for translocation, and a peptide within a carboxyl terminal fragment. The present invention further comprising a composition of antibody, which conjugates to E7 peptide, wherein the nucleotide sequence corresponding to the amino acid sequence of the E7 peptide is shown as SEQ. ID. NO.1.